(1-(Thiophen-3-ylmethyl)piperidin-4-yl)methanol

Catalog No.: 
ACTXAC545
CAS No.: 
1249314-74-6
Molecular Formula: 
C11H17NOS
Molecular Weight: 
211.33
(1-(Thiophen-3-ylmethyl)piperidin-4-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$373.00InquiryInquiry
1g95%$1119.00InquiryInquiry
5g95%$3372.00InquiryInquiry
10g95%$4715.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(Thiophen-3-ylmethyl)piperidin-4-yl)methanol
IUPAC Name(1-(thiophen-3-ylmethyl)piperidin-4-yl)methanol
MDL No.MFCD16162920
Molecular FormulaC11H17NOS
Molecular Weight211.33
SMILESOCC1CCN(CC2=CSC=C2)CC1
InChI KeyOSDZUHZXDXBTNC-UHFFFAOYSA-N
Synonym{1-[(THIOPHEN-3-YL)METHYL]PIPERIDIN-4-YL}METHANOL;4-Piperidinemethanol, 1-(3-thienylmethyl)-
CAS No.1249314-74-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTXAC545 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDMIL769 route compound structure diagram
    ACDMIL769498-62-4In Stock
  2. Plus
  3. ACEOQB694 route compound structure diagram
    ACEOQB69490748-01-9In Stock
  4. Then
  5. ACTXAC545 route product structure diagram
    ACTXAC5451249314-74-6
Inquiry

2. ACTXAC545 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXAC545 route product structure diagram
    ACTXAC5451249314-74-6
Inquiry

3. ACTXAC545 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXAC545 route product structure diagram
    ACTXAC5451249314-74-6
Inquiry

Comments (0)